Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. - Wikidata - wikimedia - TriplyDB

Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.

Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.

http://www.wikidata.org/entity/Q34591010

about

Cardiac cachexia: hic et nunc MicroRNA-Regulated Proinflammatory Cytokines in Sarcopenia Pharmacological perspectives in sarcopenia: a potential role for renin-angiotensin system blockers?Mitochondria in the Aging Muscles of Flies and Mice: New Perspectives for Old Characters Sarcopaenia and rheumatoid arthritis.Osteoporosis, obesity, and sarcopenia on abdominal CT: a review of epidemiology, diagnostic criteria, and management strategies for the reporting radiologist.Measuring the musculoskeletal aging phenotype.Using relative handgrip strength to identify children at risk of sarcopenic obesity.Panoramic ultrasound: a novel and valid tool for monitoring change in muscle mass Frailty and sarcopenia in elderly.Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.Muscle wasting and cachexia in heart failure: mechanisms and therapies.Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people Association between Thigh Muscle Volume and Leg Muscle Power in Older Women.Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly.Request for regulatory guidance for cancer cachexia intervention trials.Rapid screening for sarcopenia Deranged iron status in psoriasis: the impact of low body mass.Aging Reduces the Activation of the mTORC1 Pathway after Resistance Exercise and Protein Intake in Human Skeletal Muscle: Potential Role of REDD1 and Impaired Anabolic Sensitivity Evaluation of C-terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation.A robust neuromuscular system protects rat and human skeletal muscle from sarcopenia Osteosarcopenic obesity in women: impact, prevalence, and management challenges The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action.Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function.The wasting continuum in heart failure: from sarcopenia to cachexia.Advances in pharmacologic strategies for cancer cachexia.Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches.Autophagy as a Potential Target for Sarcopenia.Alternate Mediterranean diet score is positively associated with skeletal muscle mass index in middle-aged adults.Heart failure and kidney dysfunction: epidemiology, mechanisms and management.Plasma Biomarkers of Poor Muscle Quality in Older Men and Women from the Baltimore Longitudinal Study of Aging Oral health and the frailty syndrome.Muscle wasting in ageing and chronic illness.Publication trends in cachexia and sarcopenia in elderly heart failure patients.Soy-Dairy Protein Blend or Whey Protein Isolate Ingestion Induces Similar Postexercise Muscle Mechanistic Target of Rapamycin Complex 1 Signaling and Protein Synthesis Responses in Older Men.Aging effect on the instrumented Timed-Up-and-Go test variables in nursing home women aged 80-93 years.Welcome to the ICD-10 code for sarcopenia.Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016 Moving upwards - the journal of cachexia, sarcopenia and muscle in 2016.Corrigendum.

P2860

Q26744140-AAF513E4-567A-418E-8DCA-9C1FE9879571 Q26744385-ACA5C605-6FD4-4C1D-BAC5-68E19CF1267E Q26775758-BF71AE7A-6CB8-417D-8A9A-979E74A868FE Q28074180-FF58601A-9EEA-43FB-BD90-D6216830B3E7 Q30234376-E4CCEB1B-752D-43D3-A6B2-DC8DDD116644 Q30234912-CB9B7F16-B25E-41D6-88E3-B453561773AE Q30251460-64FDFEA8-FDB5-4806-A013-802DAD5CEFFD Q33719092-0B66F175-D985-4275-8421-D08328A0B504 Q33813569-F519ABFA-CFDC-4BF3-8F9F-9A4B482F1054 Q34541169-74BF2B20-2BAE-4D08-8858-5A1AC0AF86A6 Q34556525-A29754EF-48A1-449E-88F2-29297867D359 Q34681621-FE034258-A3E5-45B1-8B8B-190B840DB191 Q35617521-9E8ABB2E-D820-4C36-AC53-C35F93574AA6 Q36055477-E51A28C6-E62F-43E5-AF0F-A2CCD5901E3D Q36221501-7A991D53-F21E-47B7-990D-68E322C79393 Q36349332-C3C66BB3-F38F-43B3-B2B7-C3A3C178C9BA Q36349343-AB5ACF8D-9BC4-4A9E-8F13-A183E6CAF647 Q36349371-4D5CB428-A876-4D3C-A855-9B664909E3F1 Q36507525-BBFEA78A-A69E-4F69-ADF3-150288754A9D Q36706602-538955BC-9B3A-4BB4-AED9-CDB94B77C789 Q37049101-A9707008-B210-4FDB-A809-B0AA406827D3 Q37594598-3DC8AF62-02D5-4830-925D-721E260D4286 Q37647952-85FB046D-465D-4CD3-9121-9961A1AA9B70 Q37734859-8012E8A0-20CE-41EE-96EA-E54135CDFA64 Q38564746-FABB9EAF-4A7D-49CD-81F6-CC4AEF0CC1CB Q38578582-2165C966-FA05-4C20-A575-1285CF399515 Q38587970-54FB9D47-9F0E-4819-B777-9B918BE665D2 Q38637495-D069D841-0970-41DB-B4F0-D1BFC66BC57E Q38780335-2CCB5F6E-A69C-4DCD-A0A5-6C993FD4A275 Q38826590-0D5FDB3A-223D-4F2F-BD1A-714B64444F13 Q38888109-B1AA18A3-2C0C-4B40-97E5-203BAFEEAFD8 Q38921865-1C6CC024-035C-4D2C-B37D-81D8E0C2C8AB Q39001205-A4F8185C-A48E-4A16-9E5D-06657321A991 Q39019268-03BDBEFA-1523-4A89-A073-7A57C706813C Q39231283-5E8757D9-5C39-4E7B-9120-4689A98AED27 Q41039533-4A403510-867B-41C7-9C6C-9D86BB22606F Q42366308-47085E80-201B-4548-9FA6-9617EE8B8FA4 Q42366313-7E5DCED3-3AFE-48D7-80FD-D91089F560D1 Q42398018-6385805D-6772-4E42-8283-D08B552B705A Q42651671-DE2D3BCD-2A10-4EF9-9D41-B25093165750

P2860

Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.

http://www.wikidata.org/entity/Q34591010

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prevalence, incidence, and cli ...... and epidemiology-update 2014.

@en

Prevalence, incidence, and cli ...... and epidemiology-update 2014.

@nl

type

label

Prevalence, incidence, and cli ...... and epidemiology-update 2014.

@en

Prevalence, incidence, and cli ...... and epidemiology-update 2014.

@nl

prefLabel

Prevalence, incidence, and cli ...... and epidemiology-update 2014.

@en

Prevalence, incidence, and cli ...... and epidemiology-update 2014.

@nl

P1433

Q34591010-81B85E32-4F36-4FFE-9E16-A35BB3E1D134

P1476

Q34591010-5881DFD3-1A5C-487A-9712-E0E58B30CA24

P2093

Q34591010-CAB1A83F-AB5F-4A05-945E-39AAFB4B61AE

P2860

Q34591010-009D5845-4A85-4C75-94EC-D598DC81F8F4

Q34591010-062A094C-43E3-4F48-9C79-DABDAA53988D

Q34591010-072903A2-5594-49D0-B3BB-9AC3EB80B8CD

Q34591010-07FF0AE1-1C15-4791-9D34-E620EBA54974

Q34591010-08CA93DA-287B-44AB-8710-34C6A9F0CBF9

Q34591010-0C4D6E5A-44DA-4910-83C3-A64FA7D3F72E

Q34591010-0CBAFA03-F1C7-4DE6-BAD5-1E35088096C4

Q34591010-17078FB2-34E8-4455-AD6B-BFCD435B35E3

Q34591010-1A0A8284-8CFD-4791-8243-A0104F9AA591

Q34591010-1E161F97-BFAE-43ED-87FD-4C743228442F

P2888

Q34591010-69E0B3C8-EA79-4920-8F8A-1E0B60E2CCDD

P304

Q34591010-7556062D-A5C9-4817-83DA-339D146DE0AD

P31

Q34591010-77048202-CA1D-4B14-80F8-079842860059

Q34591010-8012cccc-77f0-41f9-8528-98c735b3bf6e

P356

Q34591010-8653C862-BC03-4A3D-A151-910F1E42DEE4

P433

Q34591010-DB0855E6-52E6-4B0F-B152-6B6CAB1619B7

P478

Q34591010-E87657E4-327F-4BB2-94BC-FB8D0B3BF3C1

P50

Q34591010-CFA7A768-A7E0-4B95-97F7-746CE1680FF7

Q34591010-DB1A417E-21F1-4C05-8425-0EAECB0E2863

P577

Q34591010-227BF0EE-CB84-4488-A458-D3719A51EA39

P5875

Q34591010-13A42323-4B78-46D3-B943-CB116D7D9CDC

P6179

Q34591010-9FD3E6CF-931D-4FC7-ADF6-8D3A6DCF6E83

P698

Q34591010-DDE4832F-95E2-48F3-AFEF-D608F2DFE575

P932

Q34591010-46DE2A2C-E15F-4388-9C3C-E2310E22FB64

P356

S13539-014-0161-Y

P1433

Journal of Cachexia, Sarcopenia and Muscle

P1476

Prevalence, incidence, and cli ...... and epidemiology-update 2014.

@en

P2093

John E Morley

http://www.w3.org/2001/XMLSchema#string

P2860

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

An overview of sarcopenia: facts and numbers on prevalence and clinical impact

Frailty in older adults: evidence for a phenotype

Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized s

Epidemiology of sarcopenia among the elderly in New Mexico

Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"

Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review.

Are we closer to having drugs to treat muscle wasting disease?

Frailty consensus: a call to action.

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

P2888

s13539-014-0161-y

P304

253-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13539-014-0161-Y

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Stefan D. Anker

Stephan von Haehling

P577

2014-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268880379

http://www.w3.org/2001/XMLSchema#string

P6179

1031707997

http://www.w3.org/2001/XMLSchema#string

P698

25425503

http://www.w3.org/2001/XMLSchema#string

P932

4248415

http://www.w3.org/2001/XMLSchema#string